These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

81 related items for PubMed ID: 9531280

  • 1. Inhibition of an in vitro CD4+ T cell alloresponse using altered peptide ligands.
    Daniel C, Grakoui A, Allen PM.
    J Immunol; 1998 Apr 01; 160(7):3244-50. PubMed ID: 9531280
    [Abstract] [Full Text] [Related]

  • 2. Induction of IL-4-producing CD4+ T cells by antigenic peptides altered for TCR binding.
    Tao X, Grant C, Constant S, Bottomly K.
    J Immunol; 1997 May 01; 158(9):4237-44. PubMed ID: 9126985
    [Abstract] [Full Text] [Related]

  • 3. TCR-independent pathways mediate the effects of antigen dose and altered peptide ligands on Th cell polarization.
    Grakoui A, Donermeyer DL, Kanagawa O, Murphy KM, Allen PM.
    J Immunol; 1999 Feb 15; 162(4):1923-30. PubMed ID: 9973460
    [Abstract] [Full Text] [Related]

  • 4. Viral peptide specific induction of MHC class II expression by murine T cell clones.
    Thomas DB, Smith CA, Graham CM.
    J Immunol; 1996 Sep 15; 157(6):2386-94. PubMed ID: 8805637
    [Abstract] [Full Text] [Related]

  • 5. Complete dissection of the Hb(64-76) determinant using T helper 1, T helper 2 clones, and T cell hybridomas.
    Evavold BD, Williams SG, Hsu BL, Buus S, Allen PM.
    J Immunol; 1992 Jan 15; 148(2):347-53. PubMed ID: 1370311
    [Abstract] [Full Text] [Related]

  • 6. The role of antigenic peptide in CD4+ T helper phenotype development in a T cell receptor transgenic model.
    Tamura T, Ariga H, Kinashi T, Uehara S, Kikuchi T, Nakada M, Tokunaga T, Xu W, Kariyone A, Saito T, Kitamura T, Maxwell G, Takaki S, Takatsu K.
    Int Immunol; 2004 Dec 15; 16(12):1691-9. PubMed ID: 15477229
    [Abstract] [Full Text] [Related]

  • 7. Mapping immune responses to mRBP-3 1-16 peptide with altered peptide ligands.
    Guyver CJ, Copland DA, Calder CJ, Sette A, Sidney J, Dick AD, Nicholson LB.
    Invest Ophthalmol Vis Sci; 2006 May 15; 47(5):2027-35. PubMed ID: 16639012
    [Abstract] [Full Text] [Related]

  • 8. Elucidation and role of critical residues of immunodominant peptide associated with T cell-mediated parasitic disease.
    Hernandez HJ, Stadecker MJ.
    J Immunol; 1999 Oct 01; 163(7):3877-82. PubMed ID: 10490987
    [Abstract] [Full Text] [Related]

  • 9. CD40-CD154 interaction and IFN-gamma are required for IL-12 but not prostaglandin E2 secretion by microglia during antigen presentation to Th1 cells.
    Aloisi F, Penna G, Polazzi E, Minghetti L, Adorini L.
    J Immunol; 1999 Feb 01; 162(3):1384-91. PubMed ID: 9973393
    [Abstract] [Full Text] [Related]

  • 10. Cutting edge: dueling TCRs: peptide antagonism of CD4+ T cells with dual antigen specificities.
    Robertson JM, Evavold BD.
    J Immunol; 1999 Aug 15; 163(4):1750-4. PubMed ID: 10438905
    [Abstract] [Full Text] [Related]

  • 11. Alternative metabolic states in murine macrophages reflected by the nitric oxide synthase/arginase balance: competitive regulation by CD4+ T cells correlates with Th1/Th2 phenotype.
    Munder M, Eichmann K, Modolell M.
    J Immunol; 1998 Jun 01; 160(11):5347-54. PubMed ID: 9605134
    [Abstract] [Full Text] [Related]

  • 12. TCR recognition of the Hb(64-76)/I-Ek determinant: single conservative amino acid changes in the complementarity-determining region 3 dramatically alter antigen fine specificity.
    Hsu BL, Donermeyer DL, Allen PM.
    J Immunol; 1996 Sep 15; 157(6):2291-8. PubMed ID: 8805626
    [Abstract] [Full Text] [Related]

  • 13. Antigen-specific downregulation of T cells by doxorubicin delivered through a recombinant MHC II--peptide chimera.
    Casares S, Stan AC, Bona CA, Brumeanu TD.
    Nat Biotechnol; 2001 Feb 15; 19(2):142-7. PubMed ID: 11175728
    [Abstract] [Full Text] [Related]

  • 14. T-cell receptor transgenic analysis of tumor-specific CD8 and CD4 responses in the eradication of solid tumors.
    Marzo AL, Lake RA, Robinson BW, Scott B.
    Cancer Res; 1999 Mar 01; 59(5):1071-9. PubMed ID: 10070965
    [Abstract] [Full Text] [Related]

  • 15. CD4 regulation of TCR signaling and T cell differentiation following stimulation with peptides of different affinities for the TCR.
    Leitenberg D, Boutin Y, Constant S, Bottomly K.
    J Immunol; 1998 Aug 01; 161(3):1194-203. PubMed ID: 9686579
    [Abstract] [Full Text] [Related]

  • 16. UVB-irradiated dendritic cells are impaired in their APC function and tolerize primed Th1 cells but not naive CD4+ T cells.
    Denfeld RW, Hara H, Tesmann JP, Martin S, Simon JC.
    J Leukoc Biol; 2001 Apr 01; 69(4):548-54. PubMed ID: 11310840
    [Abstract] [Full Text] [Related]

  • 17. Instruction of naive CD4+ T-cell fate to T-bet expression and T helper 1 development: roles of T-cell receptor-mediated signals.
    Ariga H, Shimohakamada Y, Nakada M, Tokunaga T, Kikuchi T, Kariyone A, Tamura T, Takatsu K.
    Immunology; 2007 Oct 01; 122(2):210-21. PubMed ID: 17490433
    [Abstract] [Full Text] [Related]

  • 18. The I-Ab-restricted alloresponse of D10.G4.1 T cells is based on the recognition of an endogenous peptide.
    Gradehandt G, Kleber N, Mattner F, Milbradt S, Rüde E.
    Immunology; 1993 Apr 01; 78(4):592-9. PubMed ID: 8495978
    [Abstract] [Full Text] [Related]

  • 19. Primary T-cell and activated macrophage response associated with tumor protection using peptide/poly-N-acetyl glucosamine vaccination.
    Maitre N, Brown JM, Demcheva M, Kelley JR, Lockett MA, Vournakis J, Cole DJ.
    Clin Cancer Res; 1999 May 01; 5(5):1173-82. PubMed ID: 10353754
    [Abstract] [Full Text] [Related]

  • 20. The replacement of graft endothelium by recipient-type cells conditions allograft rejection mediated by indirect pathway CD4+ T cells.
    Kapessidou Y, Habran C, Buonocore S, Flamand V, Barvais L, Goldman M, Braun MY.
    Transplantation; 2006 Aug 27; 82(4):582-91. PubMed ID: 16958183
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.